The COVID-19 pandemic has stressed how drug and vaccine development requires time and resources. Whilst we welcome the launch of the AMR Action Fund, its effectiveness in tackling the issue of AMR will depend on the fund’s accessibility and inclusiveness.
Reflection Paper available here.